01
Management Consulting
Our team has a combined 100+ years of experience managing brands, portfolios and departments. We provide strategic analyses and recommendations that are both meaningful and actionable, and we have been involved in due diligence assessing both drug and diagnostic assets.
Opportunity assessment
Situation analysis and competitive benchmarking that frames the real decision.
New product planning
From early pipeline shaping to the plan that carries an asset to market.
Portfolio strategy
Pipeline and portfolio gap analysis, with clear asset prioritisation.
Acquisition & ROI
Acquisition strategy and execution, promotional effectiveness and ROI.
All capabilities
- Competitive benchmarking
- New product planning
- Situation analysis
- Opportunity assessment
- Promotional effectiveness and ROI
- Secondary data analysis
- Pipeline and portfolio gap analysis
- Asset prioritisation
- Acquisition strategy and execution


